{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:42:54Z","timestamp":1786236174865,"version":"build-2736575974"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejphar.2026.179102","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:52:03Z","timestamp":1782802323000},"page":"179102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["HSP70: From molecular chaperone to integrative hub in castration-resistant prostate cancer therapeutic resistance"],"prefix":"10.1016","volume":"1030","author":[{"given":"Qiuyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxiu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9884-994X","authenticated-orcid":false,"given":"Xueni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179102_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/genes14020355","article-title":"HSP70 expression signature in renal cell carcinoma: a clinical and bioinformatic analysis approach","volume":"14","author":"Abd El-Fadeal","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ejphar.2026.179102_bib2","first-page":"386","article-title":"Convergent and divergent signaling pathways in cancer: a dual-axis model for adaptive precision oncology","volume":"39","author":"Aliasgar","year":"2025","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.ejphar.2026.179102_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1021\/acs.biochem.3c00531","article-title":"Human Hsp70 substrate-binding domains recognize distinct client proteins","volume":"63","author":"Ambrose","year":"2024","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2026.179102_bib3","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.1021\/acs.jmedchem.0c02091","article-title":"Function, therapeutic potential, and inhibition of Hsp70 chaperones","volume":"64","author":"Ambrose","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179102_bib5","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","article-title":"AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer","volume":"371","author":"Antonarakis","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179102_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s12038-007-0059-3","article-title":"Heat shock genes - integrating cell survival and death","volume":"32","author":"Arya","year":"2007","journal-title":"J. Biosci."},{"key":"10.1016\/j.ejphar.2026.179102_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0309491","article-title":"Identification of druggable targets from the interactome of the Androgen Receptor and Serum Response Factor pathways in prostate cancer","volume":"19","author":"Azam","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179102_bib8","doi-asserted-by":"crossref","first-page":"62529","DOI":"10.1021\/acsomega.5c05832","article-title":"Unraveling the molecular inhibition and conformational changes of Hsp70 and Hsc70 induced by VER-155008, a competitive ATPase inhibitor through molecular dynamics simulations and principal component analysis","volume":"10","author":"Barbosa da Silva","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejphar.2026.179102_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.883694","article-title":"CAR T cells targeting membrane-bound Hsp70 on tumor cells mimic Hsp70-Primed NK cells","volume":"13","author":"Bashiri Dezfouli","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.179102_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.848682","article-title":"SHetA2 attack on mortalin and colleagues in cancer therapy and prevention","volume":"10","author":"Benbrook","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2026.179102_bib11","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1038\/cddis.2010.50","article-title":"Androgens modulate autophagy and cell death via regulation of the endoplasmic reticulum chaperone glucose-regulated protein 78\/BiP in prostate cancer cells","volume":"1","author":"Bennett","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2026.179102_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8290.CD-15-1263","article-title":"The master neural transcription factor BRN2 is an androgen receptor-suppressed driver of neuroendocrine differentiation in prostate cancer","volume":"7","author":"Bishop","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejphar.2026.179102_bib13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41571-024-00903-0","article-title":"Current understanding and management of CAR T cell-associated toxicities","volume":"21","author":"Brudno","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2026.179102_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.tibs.2016.01.003","article-title":"Heat shock proteins promote cancer: it's a protection racket","volume":"41","author":"Calderwood","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejphar.2026.179102_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejphar.2026.179102_bib16","first-page":"351","article-title":"CHIP: a Co-chaperone for degradation by the proteasome and lysosome","volume":"101","author":"Chakraborty","year":"2023"},{"key":"10.1016\/j.ejphar.2026.179102_bib17","first-page":"457","article-title":"Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells","volume":"120","author":"Chalmin","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2026.179102_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1766192","article-title":"Monitoring HSP70 exosomes in cancer patients' follow up: a clinical prospective pilot study","volume":"9","author":"Chanteloup","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ejphar.2026.179102_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40814-020-00577-2","article-title":"Membrane-bound exosomal HSP70 as a biomarker for detection and monitoring of malignant solid tumours: a pilot study","volume":"6","author":"Chanteloup","year":"2020","journal-title":"Pilot Feasibility Stud."},{"key":"10.1016\/j.ejphar.2026.179102_bib20","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/s41388-024-03081-6","article-title":"Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer","volume":"43","author":"Chen","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2026.179102_bib21","article-title":"CAF-mediated regulation of prostate cancer stem cell stemness via the Wnt\/\u03b2-catenin and SDF-1\/CXCR4 pathways in castration-resistant prostate cancer","volume":"13","author":"Chen","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2026.179102_bib22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.eururo.2021.12.039","article-title":"Pre-existing castration-resistant prostate cancer-like cells in primary prostate cancer promote resistance to hormonal therapy","volume":"81","author":"Cheng","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2026.179102_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/cancers17010002","article-title":"Spatial genomics identifies heat shock proteins as key molecular changes associated to adipose periprostatic space invasion in prostate cancer","volume":"17","author":"Cussenot","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2026.179102_bib24","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1016\/j.febslet.2007.05.039","article-title":"The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions","volume":"581","author":"Daugaard","year":"2007","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.ejphar.2026.179102_bib25","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1530\/ERC-19-0420","article-title":"The epigenetic and transcriptional landscape of neuroendocrine prostate cancer","volume":"27","author":"Davies","year":"2020","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ejphar.2026.179102_bib26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ymthe.2017.01.011","article-title":"Inducible Caspase-9 selectively modulates the toxicities of CD19-Specific chimeric antigen receptor-modified T cells","volume":"25","author":"Diaconu","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejphar.2026.179102_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1158\/1535-7163.MCT-18-0432","article-title":"Hsp70 binds to the androgen receptor N-terminal domain and modulates the receptor function in prostate cancer cells","volume":"18","author":"Dong","year":"2019","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejphar.2026.179102_bib28","doi-asserted-by":"crossref","first-page":"pgad115","DOI":"10.1093\/pnasnexus\/pgad115","article-title":"Mitoribosome sensitivity to HSP70 inhibition uncovers metabolic liabilities of castration-resistant prostate cancer","volume":"2","author":"Echtenkamp","year":"2023","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.ejphar.2026.179102_bib29","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3390\/cancers13071534","article-title":"Androgen receptor-dependent mechanisms mediating drug resistance in prostate cancer","volume":"13","author":"Ehsani","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2026.179102_bib30","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.4049\/jimmunol.177.9.5946","article-title":"Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells","volume":"177","author":"Enomoto","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2026.179102_bib31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2174\/1568009614666140926122846","article-title":"Heat shock proteins as prognostic markers of cancer","volume":"14","author":"Evgeniya","year":"2014","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejphar.2026.179102_bib32","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1080\/15548627.2021.1917130","article-title":"Acetylation-dependent regulation of TPD52 isoform 1 modulates chaperone-mediated autophagy in prostate cancer","volume":"17","author":"Fan","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2026.179102_bib33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fphar.2014.00235","article-title":"The inducible caspase-9 suicide gene system as a \"safety switch\" to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells","volume":"5","author":"Gargett","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179102_bib34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41467-018-08133-6","article-title":"ONECUT2 is a driver of neuroendocrine prostate cancer","volume":"10","author":"Guo","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179102_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cytogfr.2025.09.002","article-title":"Heat shock protein 70 (Hsp70) as a target for advancing immunotherapy in solid tumors","volume":"86","author":"Hachani","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejphar.2026.179102_bib36","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/ijms26020802","article-title":"Exosomal liquid biopsy in prostate cancer: a systematic review of biomarkers for diagnosis, prognosis, and treatment response","volume":"26","author":"Hamid","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179102_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105713","article-title":"Delivering hydrophilic peptide inhibitors of heat shock protein 70 into cancer cells","volume":"122","author":"Han","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejphar.2026.179102_bib38","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.3390\/ijms22158077","article-title":"Mitochondrial HSP70 chaperone system-the influence of post-translational modifications and involvement in human diseases","volume":"22","author":"Havalov\u00e1","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179102_bib39","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1158\/0008-5472.CAN-24-3687","article-title":"Divergent clonal evolution and early dissemination promote genetic heterogeneity of metastases in castration-resistant prostate cancer","volume":"85","author":"Hosseini","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179102_bib40","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1109\/TCBB.2024.3378155","article-title":"Network modeling and control of dynamic disease pathways, review and perspectives","volume":"21","author":"Hsiao","year":"2024","journal-title":"IEEE ACM Trans. Comput. Biol. Bioinf"},{"key":"10.1016\/j.ejphar.2026.179102_bib41","article-title":"Diversity of extracellular HSP70 in cancer: advancing from a molecular biomarker to a novel therapeutic target","volume":"14","author":"Hu","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2026.179102_bib42","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1039\/D5MD00726G","article-title":"Design and evaluation of an HSP70-targeting PROTAC in synergy with an HSF1 inhibitor for enhanced antitumor activity","volume":"17","author":"Huang","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179102_bib43","doi-asserted-by":"crossref","first-page":"19169","DOI":"10.1021\/acs.jmedchem.5c01279","article-title":"Revealing GRP75-Mediated mitochondrial stability that promotes breast cancer survival through subcellular anchoring of 70 kDa heat shock protein inhibitors","volume":"68","author":"Jiang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179102_bib44","article-title":"PI3K\/AKT\/mTOR axis in cancer: from pathogenesis to treatment","volume":"6","author":"Jiang","year":"2025","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.ejphar.2026.179102_bib45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00345-025-05760-9","article-title":"Piperlongumine enhances the antitumor efficacy of PD-1 inhibitors by inducing immunogenic cell death in prostate cancer cells","volume":"43","author":"Jiang","year":"2025","journal-title":"World J. Urol."},{"key":"10.1016\/j.ejphar.2026.179102_bib46","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijbiomac.2019.12.236","article-title":"Thermal aggregates of human mortalin and Hsp70-1A behave as supramolecular assemblies","volume":"146","author":"Kiraly","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejphar.2026.179102_bib47","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1742-1241.2011.02799.x","article-title":"Characterising the castration-resistant prostate cancer population: a systematic review","volume":"65","author":"Kirby","year":"2011","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ejphar.2026.179102_bib48","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/cas.13318","article-title":"Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells","volume":"108","author":"Kita","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejphar.2026.179102_bib49","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0360-3016(03)00629-1","article-title":"Heat shock protein 70 (Hsp70) membrane expression on head-and-neck cancer biopsy-a target for natural killer (NK) cells","volume":"57","author":"Kleinjung","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejphar.2026.179102_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40139-022-00230-y","article-title":"Dynamics and sensitivity of signaling pathways","volume":"10","author":"Kochen","year":"2022","journal-title":"Curr. Pathobiol. Rep."},{"key":"10.1016\/j.ejphar.2026.179102_bib51","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149906","article-title":"A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60","volume":"132","author":"Kumar","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2026.179102_bib52","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2412246122","article-title":"Stress-induced translocation of the endoplasmic reticulum chaperone GRP78\/BiP and its impact on human disease and therapy","volume":"122","author":"Lee","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejphar.2026.179102_bib53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","article-title":"The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions","volume":"42","author":"Lei","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2026.179102_bib54","article-title":"Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancer","author":"Li","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejphar.2026.179102_bib55","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","article-title":"Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones","volume":"186","author":"Liang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.179102_bib56","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1038\/s41388-021-01914-2","article-title":"ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signaling","volume":"40","author":"Liu","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2026.179102_bib58","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1038\/s41467-018-07178-x","article-title":"Proteostasis by STUB1\/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer","volume":"9","author":"Liu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179102_bib57","article-title":"MP37-03 modulating HSP70\/STUB1 machinery by novel small molecules overcomes enzalutamide resistance in lethal prostate cancer","volume":"203","author":"Liu","year":"2020","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2026.179102_bib59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semcancer.2020.02.006","article-title":"PROTACs: a novel strategy for cancer therapy","volume":"67","author":"Liu","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejphar.2026.179102_bib60","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s13659-025-00586-9","article-title":"Targeting Hsp70 triggers ferroptosis: a novel anti-cancer mechanism of a marine natural product in prostate cancer","volume":"16","author":"Liu","year":"2026","journal-title":"Nat. Prod. Bioprospect."},{"key":"10.1016\/j.ejphar.2026.179102_bib61","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/pro.3725","article-title":"Structural and functional analysis of the Hsp70\/Hsp40 chaperone system","volume":"29","author":"Liu","year":"2020","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejphar.2026.179102_bib62","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jconrel.2021.02.020","article-title":"Combination of MAPK inhibition with photothermal therapy synergistically augments the anti-tumor efficacy of immune checkpoint blockade","volume":"332","author":"Liu","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejphar.2026.179102_bib63","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3390\/cancers11101449","article-title":"Increased plasmatic levels of PSA-expressing exosomes distinguish prostate cancer patients from benign prostatic hyperplasia: a prospective study","volume":"11","author":"Logozzi","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2026.179102_bib64","doi-asserted-by":"crossref","first-page":"10503","DOI":"10.1021\/acs.jmedchem.5c01250","article-title":"RIPTACs for precision cancer therapy: a novel modality with the inspiration of HLD-0915 as the first candidate in clinical trials","volume":"68","author":"Ma","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179102_bib65","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","article-title":"Tumor antigen escape from CAR T-cell therapy","volume":"8","author":"Majzner","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejphar.2026.179102_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105145","article-title":"The disruption of protein-protein interactions as a therapeutic strategy for prostate cancer","volume":"161","author":"Matos","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2026.179102_bib67","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1038\/srep09363","article-title":"Functional diversification and specialization of cytosolic 70-kDa heat shock proteins","volume":"5","author":"McCallister","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179102_bib68","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12967-025-06115-z","article-title":"A novel peptide encoded by circSRCAP confers resistance to enzalutamide by inhibiting the ubiquitin-dependent degradation of AR-V7 in castration-resistant prostate cancer","volume":"23","author":"Meng","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.179102_bib69","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2025-3065","article-title":"Abstract 3065: tribbles 2 drives lineage maintenance and survival in neuroendocrine prostate cancer by regulating N-Myc stability","volume":"85","author":"Monga","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179102_bib70","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1007\/s10147-020-01777-9","article-title":"Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis","volume":"25","author":"Mori","year":"2020","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2026.179102_bib71","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1158\/0008-5472.CAN-17-3728","article-title":"Targeting the Hsp40\/Hsp70 chaperone axis as a novel strategy to treat castration-resistant prostate cancer","volume":"78","author":"Moses","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179102_bib72","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.185952","article-title":"ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancer","volume":"9","author":"Nouruzi","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejphar.2026.179102_bib73","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1158\/0008-5472.CAN-17-0976","article-title":"Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancer","volume":"77","author":"Ponnusamy","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179102_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.692574","article-title":"PROTAC: an effective targeted protein degradation strategy for cancer therapy","volume":"12","author":"Qi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179102_bib75","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-24-1388","article-title":"Neuroendocrine differentiation in prostate cancer requires ASCL1","volume":"84","author":"Rodarte","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179102_bib76","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nature19807","article-title":"The epichaperome is an integrated chaperome network that facilitates tumour survival","volume":"538","author":"Rodina","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.179102_bib77","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/s43018-024-00838-6","article-title":"The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1","volume":"5","author":"Romero","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ejphar.2026.179102_bib78","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1158\/1535-7163.MCT-23-0747","article-title":"PROTACs: current and future potential as a precision medicine strategy to combat cancer","volume":"23","author":"Rutherford","year":"2024","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejphar.2026.179102_bib79","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s41467-017-01269-x","article-title":"Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer","volume":"8","author":"Samaranayake","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179102_bib80","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyag172","article-title":"Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castrate-resistant prostate cancer: a pooled analysis","author":"Saxena","year":"2026","journal-title":"Oncologist"},{"key":"10.1016\/j.ejphar.2026.179102_bib81","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.1074\/jbc.RA119.012449","article-title":"Functional diversity between HSP70 paralogs caused by variable interactions with specific co-chaperones","volume":"295","author":"Serlidaki","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179102_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110492","article-title":"The multifunction of HSP70 in cancer: guardian or traitor to the survival of tumor cells and the next potential therapeutic target","volume":"122","author":"Sha","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2026.179102_bib83","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1021\/acs.jmedchem.4c02205","article-title":"Discovery of a potent and selective GSPT1 molecular glue degrader for the treatment of castration-resistant Prostate Cancer","volume":"68","author":"Shen","year":"2025","journal-title":"J Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179102_bib84","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1021\/acs.jmedchem.1c02221","article-title":"Rational design for nitroreductase (NTR)-responsive proteolysis targeting chimeras (PROTACs) selectively targeting tumor tissues","volume":"65","author":"Shi","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179102_bib85","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.chembiol.2022.01.008","article-title":"Selective vulnerabilities in the proteostasis network of castration-resistant prostate cancer","volume":"29","author":"Shkedi","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejphar.2026.179102_bib86","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.3390\/ijms25105483","article-title":"Molecular chaperonin HSP60: current understanding and future prospects","volume":"25","author":"Singh","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179102_bib87","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s11658-023-00458-5","article-title":"Hsp70-Bim interaction facilitates mitophagy by recruiting parkin and TOMM20 into a complex","volume":"28","author":"Song","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.ejphar.2026.179102_bib88","doi-asserted-by":"crossref","first-page":"6817","DOI":"10.1038\/s41467-024-51020-6","article-title":"Insect ribosome-rescuer Pelo-Hbs1 complex on sperm surface mediates paternal arbovirus transmission","volume":"15","author":"Sun","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179102_bib89","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2026.179102_bib90","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/ERC-13-0326","article-title":"Androgen receptor co-regulatory networks in castration-resistant prostate cancer","volume":"21","author":"Sung","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ejphar.2026.179102_bib91","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1111\/cas.16349","article-title":"Selective killing of castration-resistant prostate cancer cells by formycin A via the ATF4\u2013CHOP axis","volume":"115","author":"Takei","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejphar.2026.179102_bib92","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/path.2795","article-title":"GRP78 up-regulation is associated with androgen receptor status, Hsp70-Hsp90 client proteins and castrate-resistant prostate cancer","volume":"223","author":"Tan","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejphar.2026.179102_bib93","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2026.179102_bib94","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.3390\/ijms21218277","article-title":"Dual-inhibitors of N-Myc and AURKA as potential therapy for neuroendocrine prostate cancer","author":"Ton","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179102_bib95","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2021-2","article-title":"Abstract 2: addressing treatment resistance in models of lethal prostate cancer","volume":"81","author":"Vasciaveo","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179102_bib96","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1279372","article-title":"Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: role of HSP70\/TLR2\/NF-kB axis","volume":"6","author":"Vulpis","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ejphar.2026.179102_bib97","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-024-02024-9","article-title":"New-generation advanced PROTACs as potential therapeutic agents in cancer therapy","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejphar.2026.179102_bib98","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jnci\/djab071","article-title":"Comparison of treatments for nonmetastatic castration-resistant prostate cancer: matching-adjusted indirect comparison and network meta-analysis","volume":"114","author":"Wang","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejphar.2026.179102_bib99","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1093\/nar\/gkae938","article-title":"EGFR-mediated HSP70 phosphorylation facilitates PCNA association with chromatin and DNA replication","volume":"52","author":"Wang","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2026.179102_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113452","article-title":"A novel Hsp70 inhibitor specifically targeting the cancer-related Hsp70-Bim protein-protein interaction","volume":"220","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179102_bib101","doi-asserted-by":"crossref","first-page":"16377","DOI":"10.1021\/acs.jmedchem.3c01783","article-title":"Exploiting the \"Hot-Spots\" of Hsp70-Bim protein-protein interaction to optimize the 1-Oxo-1H-phenalene-2,3-dicarbonitrile analogues as specific Hsp70-Bim inhibitors","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179102_bib102","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2026.179102_bib103","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2026.179102_bib104","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.3390\/cancers13153706","article-title":"Hsp70 in liquid Biopsies-A tumor-specific biomarker for detection and response monitoring in cancer","volume":"13","author":"Werner","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2026.179102_bib105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-3-030-40204-4_11","article-title":"Reflections and outlook on targeting HSP90, HSP70 and HSF1 in cancer: a personal perspective","volume":"1243","author":"Workman","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejphar.2026.179102_bib106","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13277-013-1024-4","article-title":"Glucose-regulated protein 78 mediates hormone-independent prostate cancer progression and metastasis through maspin and COX-2 expression","volume":"35","author":"Wu","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.ejphar.2026.179102_bib107","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1038\/s41388-020-1285-5","article-title":"Mortalin\/HSPA9 targeting selectively induces KRAS tumor cell death by perturbing mitochondrial membrane permeability","volume":"39","author":"Wu","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2026.179102_bib108","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/md23060258","article-title":"Targeting ferroptosis in tumors: novel marine-derived compounds as regulators of lipid peroxidation and GPX4 signaling","volume":"23","author":"Wu","year":"2025","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejphar.2026.179102_bib109","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.3390\/biomedicines11082276","article-title":"Hsp70-A universal biomarker for predicting therapeutic failure in human female cancers and a target for CTC isolation in advanced cancers","volume":"11","author":"Xanthopoulos","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2026.179102_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107131","article-title":"Study of novel ginsenoside metabolites targeting HSP70 as anti-prostate cancer drugs","volume":"144","author":"Xu","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejphar.2026.179102_bib111","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/ph18081241","article-title":"Network pharmacology and experimental validation identify paeoniflorin as a novel SRC-targeted therapy for castration-resistant prostate cancer","volume":"18","author":"Xu","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejphar.2026.179102_bib112","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1038\/s41467-024-50459-x","article-title":"Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer","volume":"15","author":"Xu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179102_bib113","article-title":"Abstract 4491: HSP70 leverages STUB1 to modulate N-Myc protein turnover in lethal prostate cancer","volume":"85","author":"Xu","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179102_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106692","article-title":"Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models","volume":"189","author":"Xu","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2026.179102_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167630","article-title":"Synergistic anticancer activity of HSP70 and HSF1 inhibitors in colorectal cancer cells: a new strategy for combination therapy","volume":"1871","author":"Xu","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2026.179102_bib116","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41388-025-03328-w","article-title":"A mitochondrial outer membrane protein TOMM20 maintains protein stability of androgen receptor and regulates AR transcriptional activity in prostate cancer cells","volume":"44","author":"Yin","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2026.179102_bib117","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13046-023-02776-0","article-title":"AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer","volume":"42","author":"Yin","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179102_bib118","doi-asserted-by":"crossref","first-page":"12528","DOI":"10.1074\/jbc.M117.785675","article-title":"The ubiquitin ligase STUB1 regulates stability and activity of RUNX1 and RUNX1\u2013RUNX1T1","volume":"292","author":"Yonezawa","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179102_bib119","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s11658-023-00450-z","article-title":"Single-cell omics traces the heterogeneity of prostate cancer cells and the tumor microenvironment","volume":"28","author":"Yu","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.ejphar.2026.179102_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.146064","article-title":"The E3 ubiquitin ligase STUB1 inhibits glioblastoma progression though promoting IKK\u03b1 ubiquitination and blocking NF-\u03baB signaling pathway","volume":"321","author":"Zhang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejphar.2026.179102_bib121","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41419-024-06621-w","article-title":"Nuclear receptor NURR1 functions to promote stemness and epithelial-mesenchymal transition in prostate cancer via its targeting of Wnt\/\u03b2-catenin signaling pathway","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2026.179102_bib122","doi-asserted-by":"crossref","first-page":"118","DOI":"10.62347\/GRQJ8158","article-title":"RB1 and p53 are diagnostic markers for treatment-related neuroendocrine prostate cancer: a clinical and pathological analysis of 23 cases","volume":"13","author":"Zhang","year":"2025","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"10.1016\/j.ejphar.2026.179102_bib123","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3390\/biom13040601","article-title":"HSP70 family in cancer: signaling mechanisms and therapeutic advances","volume":"13","author":"Zhao","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2026.179102_bib124","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Targeted Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926005844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926005844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:24:21Z","timestamp":1786235061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926005844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":124,"alternative-id":["S0014299926005844"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179102","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HSP70: From molecular chaperone to integrative hub in castration-resistant prostate cancer therapeutic resistance","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179102"}}